arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Connect Biopharma Holdings Limited

CNTB Health Care Biotechnology: Pharmaceutical Preparations
$1.88
▲ +2.3% Today
as of Sep 4, 16:47 ET
Last 30 days -12.38% Jul 27 → Sep 04
$1.77 $2.03 $2.30 $2.57 $2.83 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$2.01
High
$2.03
Low
$1.74
Volume
$2M
Avg Vol
$316,640
Mkt Cap
$144M
P/E (TTM)
—
Beta
—
52w High
$3.82
52w Low
$1.23
Div Yield
—
Shares Out
$63M

Recent Press Releases & News last 60 days · 3 items

Sep 3 · 20:05 PR GlobeNewswire
Connect Biopharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Aug 12 · 20:05 PR GlobeNewswire
Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update
Jul 9 · 12:30 MT Newswires
Oppenheimer Initiates Connect Biopharma at Outperform With $8 Price Target

Overview

52-week range
$1.23
$3.82
25% of range
Avg surprise (last 3)
+1.7%
Avg reaction (last 2)
+4.5%
50% positive
Latest IV / EM
329%
EM ±51.4% · $3 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.34$-0.19$-0.03$0.12$0.27 Actual $-0.16Actual $0.27Actual $-0.23Actual $-0.19Est $-0.26Actual $-0.23Est $-0.22Actual $-0.31Actual $-0.34Est $-0.29Actual $-0.27 MarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-19M$-14M$-8M$-3M$3M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.27 — — — — financials
Tue May 12, 2026Mar/2026 $-0.34 $-0.29 -17.2% -79.0% +14.5% earnings
Tue Sep 30, 2025Sep 2025 $-0.31 — — — — financials
Wed Aug 13, 2025Jun/2025 $-0.23 $-0.22 -4.5% — — earnings
Thu May 15, 2025Mar/2025 $-0.19 $-0.26 +26.9% — -5.6% earnings
Mon Sep 30, 2024Sep 2024 $-0.23 — — — — financials
Sun Jun 30, 2024Jun 2024 $0.27 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.16 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$3M$169,000—$16,000$48,000$0—$1M
Cost of revenue————————
Gross profit————————
Operating income$-18M$-20M—$-18M$-13M$-11M—$-14M
Net income$-17M$-19M—$-17M$-13M$-10M—$-13M
EPS (diluted)$-0.27$-0.34—$-0.31$-0.23$-0.19—$-0.23

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$27M$46M$38M$38M$41M$48M$78M—
Inventory————————
Total current assets$39M$55M$51M$63M$78M$88M$97M—
Total assets$43M$60M$56M$67M$83M$93M$101M—
Long-term debt————————
Total liabilities$17M$17M$14M$12M$11M$10M$9M—
Total equity$27M$43M$42M$55M$71M$83M$92M$101M

Implied volatility — last 90 days

121%379%636%893%1151% Jun 07 — IV 200% · EM ±27.6%Jun 08 — IV 207% · EM ±27.3%Jun 09 — IV 226% · EM ±28.3%Jun 10 — IV 265% · EM ±31.2%Jun 11 — IV 302% · EM ±33.3%Jun 12 — IV 300% · EM ±30.7%Jun 15 — IV 503% · EM ±36.4%Jun 16 — IV 723% · EM ±42.7%Jun 17 — IV 1151% · EM ±48.1%Jul 01 — IV 144% · EM ±24.1%Jul 02 — IV 151% · EM ±24.4%Jul 07 — IV 205% · EM ±27.0%Jul 08 — IV 216% · EM ±27.0%Jul 10 — IV 126% · EM ±13.9%Jul 13 — IV 282% · EM ±23.6%Jul 14 — IV 205% · EM ±14.9%Jul 15 — IV 279% · EM ±16.5%Jul 16 — IV 461% · EM ±19.3%Jul 20 — IV 180% · EM ±42.6%Jul 21 — IV 185% · EM ±43.0%Jul 22 — IV 189% · EM ±43.2%Jul 23 — IV 192% · EM ±43.2%Jul 24 — IV 222% · EM ±49.1%Jul 27 — IV 239% · EM ±50.0%Jul 29 — IV 158% · EM ±31.7%Jul 30 — IV 134% · EM ±26.3%Aug 03 — IV 129% · EM ±22.8%Aug 04 — IV 126% · EM ±21.7%Aug 05 — IV 122% · EM ±20.4%Aug 07 — IV 189% · EM ±29.5%Aug 24 — IV 265% · EM ±55.4%Aug 25 — IV 200% · EM ±40.8%Aug 26 — IV 236% · EM ±47.2%Aug 27 — IV 190% · EM ±37.3%Aug 28 — IV 223% · EM ±42.6%Aug 31 — IV 326% · EM ±57.7%Sep 01 — IV 234% · EM ±40.3%Sep 02 — IV 369% · EM ±61.6%Sep 03 — IV 412% · EM ±66.6%Sep 04 — IV 329% · EM ±51.4%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in